Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of Class IIa HDAC Activities: It is Not Only Matter of Subcellular Localization
Eros Di Giorgio, Claudio Brancolini
Epigenomics (2016) Vol. 8, Iss. 2, pp. 251-269
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability
Giorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, et al.
Genes (2020) Vol. 11, Iss. 5, pp. 556-556
Open Access | Times Cited: 271
AMPK: Regulation of Metabolic Dynamics in the Context of Autophagy
Isaac Tamargo‐Gómez, Guillermo Mariño
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3812-3812
Open Access | Times Cited: 213
MOF Acetyl Transferase Regulates Transcription and Respiration in Mitochondria
Aindrila Chatterjee, Janine Seyfferth, Jacopo Lucci, et al.
Cell (2016) Vol. 167, Iss. 3, pp. 722-738.e23
Open Access | Times Cited: 153
A FAK/HDAC5 signaling axis controls osteocyte mechanotransduction
Tadatoshi Sato, Shiv Kumar Verma, Christian Castro, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 75
The Wnt pathway: An important control mechanism in bone's response to mechanical loading
Roy B. Choi, Alexander G. Robling
Bone (2021) Vol. 153, pp. 116087-116087
Open Access | Times Cited: 56
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
Jingjing Pu, Ting Liu, Xuzhen Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
MEF2 and the tumorigenic process, hic sunt leones
Eros Di Giorgio, Wayne W. Hancock, Claudio Brancolini
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 2, pp. 261-273
Open Access | Times Cited: 71
Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo
Yusuke Tarumoto, Shan Lin, Jinhua Wang, et al.
Blood (2019) Vol. 135, Iss. 1, pp. 56-70
Open Access | Times Cited: 70
Complex neuroprotective and neurotoxic effects of histone deacetylases
Elizabeth A. Thomas, Santosh R. D’Mello
Journal of Neurochemistry (2018) Vol. 145, Iss. 2, pp. 96-110
Open Access | Times Cited: 67
4-hydroxyphenylpyruvate dioxygenase promotes lung cancer growth via pentose phosphate pathway (PPP) flux mediated by LKB1-AMPK/HDAC10/G6PD axis
Changliang Shan, Zhaoliang Lu, Zhen Li, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 7
Open Access | Times Cited: 62
Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation
L. Wang, Ulf H. Beier, Tatiana Akimova, et al.
American Journal of Transplantation (2018) Vol. 18, Iss. 7, pp. 1596-1603
Open Access | Times Cited: 60
Recent advances in class IIa histone deacetylases research
Yodita Asfaha, Christian Schrenk, Leandro A. Alves Avelar, et al.
Bioorganic & Medicinal Chemistry (2019) Vol. 27, Iss. 22, pp. 115087-115087
Closed Access | Times Cited: 57
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers
Eros Di Giorgio, Harikrishnareddy Paluvai, Emiliano Dalla, et al.
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 42
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
Chun Yang, Stéphane Croteau, Pierre Hardy
Cellular Oncology (2021) Vol. 44, Iss. 5, pp. 997-1017
Open Access | Times Cited: 41
Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease
Yizhuo Wang, Rishika Abrol, Jeffrey Y. W. Mak, et al.
FEBS Journal (2022) Vol. 290, Iss. 11, pp. 2805-2832
Open Access | Times Cited: 37
HDACs and the epigenetic plasticity of cancer cells: Target the complexity
Claudio Brancolini, Teresa Gagliano, Martina Minisini
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108190-108190
Open Access | Times Cited: 31
HDAC4 in cancer: A multitasking platform to drive not only epigenetic modifications
Emma Cuttini, Camilla Goi, Ester Pellarin, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17
Histone deacetylases (HDAC) in physiological and pathological bone remodelling
Melissa Cantley, Andrew C.W. Zannettino, P. Mark Bartold, et al.
Bone (2016) Vol. 95, pp. 162-174
Closed Access | Times Cited: 50
Activation of AMPK inhibits TGF-β1-induced airway smooth muscle cells proliferation and its potential mechanisms
Yilin Pan, Lu Liu, Shaojun Li, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 47
Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis
Chongxiang Xiong, Yingjie Guan, Xiaoxu Zhou, et al.
The FASEB Journal (2019) Vol. 33, Iss. 7, pp. 8249-8262
Open Access | Times Cited: 46
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
Eros Di Giorgio, Emiliano Dalla, Elisa Franforte, et al.
Nucleic Acids Research (2019) Vol. 48, Iss. 2, pp. 646-664
Open Access | Times Cited: 44
Emerging Role of HDACs in Regeneration and Ageing in the Peripheral Nervous System: Repair Schwann Cells as Pivotal Targets
Jose A. Gomez‐Sanchez, Nikiben Patel, Fernanda Martirena, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2996-2996
Open Access | Times Cited: 25
SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers
Zhen Lü, Weiqun Mao, Hailing Yang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 11
Open Access | Times Cited: 25
Histone deacetylase (HDACs) inhibitors: Clinical applications
Kumar D. Shanmukha, Harikrishnareddy Paluvai, Santosh K. Lomada, et al.
Progress in molecular biology and translational science (2023), pp. 119-152
Closed Access | Times Cited: 14
Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology
Rahul Patil, McKenzie E. Maloney, Rudolf Lucas, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 140-140
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top